Rational design of loss-of-function phospholamban mutants to tune SERCA function.

Loading...

View/Download File

Ha_umn_0130E_12667.pdf (5.5 MB)

Persistent link to this item

https://hdl.handle.net/11299/126216

Statistics

View Statistics

Journal Title

Journal ISSN

Volume Title

Title

Rational design of loss-of-function phospholamban mutants to tune SERCA function.

Authors

Ha, Kim N.

Published Date

2012-04

Publisher

Type

Thesis or Dissertation

Abstract

Unphosphorylated phospholamban (PLN) is the endogenous inhibitor of the sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA), the enzyme that regulates cardiac muscle relaxation in humans. In its phosphorylated state, PLN (pS16-PLN, pT17-PLN, and pS16pT17-PLN) does not inhibit SERCA. Dysfunctions in SERCA:PLN interactions and in the PLN phosphorylation mechanism have been implicated in cardiac disease and targeting PLN is becoming a viable avenue for treating heart disease. Specifically, innovative genetic treatments using recombinant adeno-associated virus (rAAV) with S16E-PLN, a pseudo-phosphorylated form of PLN, have shown a remarkable efficacy in reducing the progression of cardiac failure in both small and large animals. The following thesis summarizes efforts to rationally design PLN mutants to tune SERCA function. Using a combination of NMR spectroscopy and biochemical assays, we have built a structure-dynamics-function correlation that shows PLN can be tuned to augment SERCA function by acting on the conformational coupling between the cytoplasmic and transmembrane domain and by pseudo-phosphorylation. Additionally, to better understand the role of mutation in PLN:SERCA interactions, we also investigated a mutant of PLN (R9C) known to be linked to hereditary dilated cardiomyopathy, showing that the mutation disrupts the pentamer-monomer equilibrium, and that these effects are exacerbated under oxidizing conditions. Insights to these issues will provide better paradigms with which to design therapeutic mutants of PLN for treatment of heart failure.

Keywords

Calcium

Gene therapy

Membrane proteins

Phospholamban

SERCA

Spectroscopy

Biochemistry, Molecular Bio, and Biophysics

Description

University of Minnesota Ph.D. dissertation. April 2012. Major: Biochemistry, Molecular Bio, and Biophysics. Advisor: Gianluigi Veglia. 1 computer file (PDF); xiv, 161 pages.

Related to

Replaces

License

Collections

Dissertations

Series/Report Number

Funding information

Isbn identifier

Doi identifier

Previously Published Citation

Suggested citation

Ha, Kim N.. (2012). Rational design of loss-of-function phospholamban mutants to tune SERCA function.. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/126216.

Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.